Safety of simvastatin and goal attainment for low-density lipoprotein cholesterol in sultan qaboos university hospital.

@article{AlSiyabi2010SafetyOS,
  title={Safety of simvastatin and goal attainment for low-density lipoprotein cholesterol in sultan qaboos university hospital.},
  author={Khalid Al-Siyabi and Hatem L Farhan and Khalid H. Al-Rasadi and Amaal Al-Salhi and Ali T. Al-Hinai and Ibrahim Al-Zakwani},
  journal={Oman medical journal},
  year={2010},
  volume={25 4},
  pages={264-8}
}
OBJECTIVES Despite the scientific evidence of reducing cardiac events with HMG Co-A reductase inhibitors (statins) therapy in both primary and secondary preventions, these therapies continue to be underutilized in patients receiving convictional care. Simvastatin, a HMG Co-A inhibitor agent, is the most commonly used statin in Sultan Qaboos University Hospital. The aim of this study is to review the safety and the effectiveness of achieving LDL-C targets with Simvastatin according to the NCEP… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 30 references

National Heart, Lung, and Blood Institute; American College Safety of Simvastatin and Goal.

  • SM Grundy, JI Cleeman, CN Merz, HB JrBrewer, LT Clark, DB Hunninghake
  • Al-Siyabi et al
  • 2010

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes : the SANDS ( Stop Atherosclerosis in Native Diabetics Study ) trial

  • JJ Kastelein, F Akdim, ES Stroes, AH Zwinderman, ML Bots, AF Stalenhoef
  • J Am Coll Cardiol
  • 2008

Efficacy and safety of cholesterol - lowering treatment : prospective meta - analysis of data from 90 , 056 participants in 14 randomised trials of statins

  • JC LaRosa, SM Grundy, DD Waters, C Shear, P Barter, JC Fruchart
  • Lancet
  • 2005

Similar Papers

Loading similar papers…